VGLUT1 Gene

VGLUT1 Gene

Overview

The SLC17A7 (also known as VGLUT1) gene encodes the Vesicular Glutamate Transporter 1, a critical protein responsible for packaging glutamate into synaptic vesicles at excitatory nerve terminals. Located on chromosome 19q13.33, this gene is essential for glutamatergic neurotransmission in the mammalian brain. VGLUT1 is the principal vesicular glutamate transporter in the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellar cortex, where it defines the identity and quantal output of the majority of excitatory synapses[@fremeau2001][@fremeau2004].

VGLUT1 Gene

Overview

The SLC17A7 (also known as VGLUT1) gene encodes the Vesicular Glutamate Transporter 1, a critical protein responsible for packaging glutamate into synaptic vesicles at excitatory nerve terminals. Located on chromosome 19q13.33, this gene is essential for glutamatergic neurotransmission in the mammalian brain. VGLUT1 is the principal vesicular glutamate transporter in the cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellar cortex, where it defines the identity and quantal output of the majority of excitatory synapses[@fremeau2001][@fremeau2004].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">SLC17A7 (VGLUT1)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SLC17A7</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>VGLUT1, BNPI</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[57087](https://www.ncbi.nlm.nih.gov/gene/57087)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000177508</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9P2U7](https://www.uniprot.org/uniprot/Q9P2U7)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Vesicular Glutamate Transporter 1</td></tr>
<tr><td><strong>Protein Length</strong></td><td>560 amino acids (~62 kDa)</td></tr>
<tr><td><strong>Expression</strong></td><td>Cortex, Hippocampus, Cerebellum</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Gene Structure and Evolution

The SLC17A7 gene spans approximately 17.5 kb and consists of 12 exons that encode a 560-amino acid protein. It belongs to the SLC17 family of anion transporters, which evolved from a prokaryotic phosphate transporter ancestor. The gene shows conserved synteny with other VGLUT genes (SLC17A6/VGLUT2 and SLC17A8/VGLUT3) throughout vertebrate evolution[@hisano2000][@blakely1998].

Phylogenetic Relationships

• VGLUT1 (SLC17A7): Cortex, hippocampus, cerebellar cortex — predominant in adults
• VGLUT2 (SLC17A6): Thalamus, brainstem, hypothalamus — predominant in developing brain
• VGLUT3 (SLC17A8): Serotonergic neurons, cholinergic neurons, pineal gland — co-released with other neurotransmitters

Protein Structure and Function

VGLUT1 is a multipass transmembrane protein with 12 predicted transmembrane domains. The protein operates as a proton-dependent symporter, using the energy from the vacuolar H+-ATPase (V-ATPase) proton gradient to concentrate glutamate inside synaptic vesicles[@martineau2017].

Molecular Mechanism

Structural Features

• N-terminus: Cytoplasmic, contains regulatory motifs
• Transmembrane domains: 12 TMDs forming the translocation pore
• C-terminus: Contains a polyproline motif that binds endophilin A1 for synaptic vesicle recycling[@voglmaier2006]
• Dileucine motif: Essential for AP-2/AP-3 adaptor binding and endocytic retrieval

Expression Pattern

VGLUT1 exhibits a highly specific expression pattern in the adult brain[@herzog2011]:

Brain Regions

• Cerebral Cortex: Layers II-VI, particularly abundant in pyramidal neurons of layers II/III and V
• Hippocampus: CA1-CA3 pyramidal cells, dentate granule cells, mossy fiber terminals
• Cerebellar Cortex: Parallel fiber terminals (granule cells), unipolar brush cells
• Amygdala: Principal projection neurons
• Olfactory Bulb: Mitral and tufted cells

Cellular Localization

VGLUT1 protein localizes specifically to glutamatergic synaptic vesicles in presynaptic terminals. Importantly, it is excluded from GABAergic and glycinergic terminals, making it a definitive marker for excitatory synapses[@westphalen1999][@schallier2009].

Interestingly, recent studies have detected VGLUT1 in dendritic compartments, challenging the traditional view of exclusive axonal localization. This dendritic expression may support non-synaptic glutamate release or local signaling functions[marta2018].

Role in Synaptic Transmission

Quantal Properties

VGLUT1 expression level directly controls excitatory synaptic strength:

• Heterozygous deletion: ~50% VGLUT1 expression leads to proportionally smaller miniature excitatory postsynaptic currents (mEPSCs)
• Overexpression: Increased quantal size but normal release probability
• Activity-dependent trafficking: VGLUT1 redistributes between vesicle pools during sustained activity[@menteyne2009]

Vesicle Cycling

VGLUT1's interaction with endophilin A1 via its C-terminal polyproline domain is critical for synaptic vesicle recycling[@voglmaier2006]:

• Promotes fast retrieval after exocytosis
• Limits readily releasable pool size
• Provides a brake on excessive glutamate release during high-frequency stimulation

Disease Associations

Alzheimer's Disease

VGLUT1 loss is one of the earliest and most consistent synaptic biomarkers in [Alzheimer's disease](/diseases/alzheimers-disease)[@kashani2008][@rodriguezperdigon2016]:

• Post-mortem studies: VGLUT1 protein and mRNA reduced 30-50% in AD prefrontal cortex and hippocampus, correlating with Braak stage and cognitive decline
• Amyloid-beta interaction: Aβ oligomers induce VGLUT1 internalization from presynaptic membrane, reducing vesicular glutamate content before synapse loss
• Tau pathology: Hyperphosphorylated tau accumulates in VGLUT1-positive presynaptic boutons in early AD (Braak III-IV)
• CSF biomarker: VGLUT1 fragments detectable in CSF serve as a fluid biomarker for excitatory synapse loss[shen2014]

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), corticostriatal VGLUT1-positive terminals show early dysfunction[liu2014]:

• Reduced VGLUT1 immunoreactivity in the striatum reflects corticostriatal denervation
• Loss of cortical input to medium spiny neurons disrupts balanced excitatory drive
• L-DOPA treatment partially normalizes striatal VGLUT1 levels

Epilepsy

Paradoxically, while VGLUT1 loss underlies hypofunction in AD, its overexpression can cause excitotoxicity:

• SLC17A7 overexpression causes spontaneous seizures and excitotoxic neuronal death
• In temporal lobe epilepsy, VGLUT1 is upregulated in sprouted mossy fiber terminals
• Traumatic brain injury upregulates VGLUT1 in perilesional cortex

Psychiatric Disorders

• Schizophrenia: VGLUT1 mRNA reduced ~15-20% in dorsolateral prefrontal cortex and hippocampus
• Anxiety/Depression: VGLUT1 haploinsufficiency leads to exploratory and anxiety-like behavior[bello2019]
• Developmental disorders: Loss of VGLUT1 leads to delayed motor development and hyperreflexia[moomaw2014]

Therapeutic Implications

Biomarker Potential

• CSF VGLUT1: Synaptic vesicle-derived fragments evaluated alongside neurogranin and SNAP-25 in AD clinical trials
• PET ligands: Development of VGLUT1 imaging agents for in vivo visualization of excitatory synapse density

Therapeutic Targets

• VGLUT1 enhancers: Restore excitatory transmission in AD
• VGLUT1 inhibitors: Anti-epileptic potential
• Endophilin pathway: Modulate vesicle recycling without directly altering glutamate loading
• Gene therapy: AAV-mediated SLC17A7 delivery to restore VGLUT1 levels in preclinical models

Animal Models

• VGLUT1-Cre mice: Used for optogenetic manipulation of cortico-hippocampal neurons
• Conditional knockouts: Reveal region-specific functions
• Humanized mouse models: Study SLC17A7 mutations in neuropsychiatric disease

Cross-references

• [VGLUT1 Protein](/proteins/vglut1-protein)
• [SLC17A7 Gene](/genes/slc17a7) — Primary gene page
• [Glutamate Neurotransmission](/mechanisms/glutamate-neurotransmission)
• [Synaptic Vesicle Cycling](/mechanisms/synaptic-vesicle-cycling)
• [Excitotoxicity](/entities/excitotoxicity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Hippocampus](/brain-regions/hippocampus)
• [Cortex](/brain-regions/cortex)

Key References

External Links

• [NCBI Gene: SLC17A7](https://www.ncbi.nlm.nih.gov/gene/57087)
• [UniProt: Q9P2U7](https://www.uniprot.org/uniprot/Q9P2U7)
• [GeneCards: SLC17A7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC17A7)
• [Ensembl: ENSG00000177508](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177508)
• [OMIM: 605208](https://www.omim.org/entry/605208)
• [Allen Brain Atlas: SLC17A7](https://human.brain-map.org/microarray/search/show?search_term=SLC17A7)

References